RxDoctor Payments Data

Megan Shortridge, APRN

Nurse Practitioner · Beavercreek, OHNPI 1841889524

Payments from drug & device makers

$3,337in general payments, 2019–2025

Across 174 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$402
  • Amgen$379
  • UCB, Inc.$331
  • Fresenius Kabi USA, LLC$162
  • Lilly USA, LLC$115
  • plus $353 from 9 others

What the payments were for

  • Food & beverage$3,18195%
  • Education$1555%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,337 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$303,921
Medicare patients
228
Services billed
25,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab52$526,536
Humira(Cf)Adalimumab18$171,486
Enbrel SureclickEtanercept22$159,686
RinvoqUpadacitinib15$119,335
Cimzia (2 Pack)Certolizumab Pegol14$113,499
EnbrelEtanercept14$102,933
Humira PenAdalimumab12$76,126
OtezlaApremilast12$68,026
Hydroxychloroquine Sulfate370$7,349
MethotrexateMethotrexate Sodium442$6,603
Leflunomide91$6,105
Celecoxib70$4,101
Prednisone264$1,950
Tramadol Hcl101$1,031
Sulfasalazine DrSulfasalazine25$1,010

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieHumira(Cf), Rinvoq$1,596$290,82133 claims
AmgenEnbrel, Otezla$379$170,95926 claims
UCB, Inc.Cimzia (2 Pack)$331$113,49914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Beavercreek

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →